News

FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
STAT8h
U.S. health officials inject new uncertainty into approval process for Covid boosters
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot
Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...
Claims That the FDA Has Approved Ivermectin to Treat COVID-19 Are False
At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...
Novavax COVID Vaccine Moves Closer to Full FDA Approval
Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the ...
Daily Jang1d
Novavax COVID vaccine soon to receive full FDA approval
Novavax announced that it's COVID-19 vaccine could get full approval from the U.S. Food and Drug Administration soon.The ...
Novavax says its COVID-19 shot is on track for full FDA approval after delay
At FDA, full vaccine approval is the gold standard. The agency was on track to sign off on Novavax’s license by its April 1 ...
Novavax shares soar after FDA request raises hope for COVID vaccine approval
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
RFK Jr. eyes reversing CDC’s Covid-19 vaccine recommendation for children
Just 13 percent of children have gotten the latest Covid shot, according to the most recent CDC data. And after Republicans, ...
Reuters4d
As FDA delays Novavax' COVID vaccine approval, patients fight back
CHICAGO, April 24 (Reuters) - Thousands of Americans campaigning for the Novavax (NVAX.O), opens new tab COVID-19 booster got some good news this week: the FDA signaled it might still win approval ...